United States Irbesartan Market Report 2017

February 2017 | 118 pages | ID: U73F8C16D9FEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Irbesartan

Revenue, means the sales value of Irbesartan

This report studies sales (consumption) of Irbesartan in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Teva(TAPI)?
• Taj Pharmaceuticals
• Zhuhai Rundu Pharmaceutical
• HEC Group
• Zhuhai Rundu Pharmaceutical
• ISHITA ACTIVE PHARMA INGREDIENTS (API)
• Verdant Life Sciences

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II

Split by applications, this report focuses on sales, market share and growth rate of Irbesartan in each application, can be divided into

• Application 1
• Application 2

Contents

United States Irbesartan Market Report 2017

1 IRBESARTAN OVERVIEW

1.1 Product Overview and Scope of Irbesartan
1.2 Classification of Irbesartan
  1.2.1 Type I
  1.2.2 Type II
1.3 Application of Irbesartan
  1.3.1 Application
  1.3.2 Application
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Irbesartan (2012-2022)
  1.4.1 United States Irbesartan Sales and Growth Rate (2012-2022)
  1.4.2 United States Irbesartan Revenue and Growth Rate (2012-2022)

2 UNITED STATES IRBESARTAN COMPETITION BY MANUFACTURERS

2.1 United States Irbesartan Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Irbesartan Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Irbesartan Average Price by Manufactures (2015 and 2016)
2.4 Irbesartan Market Competitive Situation and Trends
  2.4.1 Irbesartan Market Concentration Rate
  2.4.2 Irbesartan Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES IRBESARTAN SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2012-2017)

3.1 United States Irbesartan Sales and Market Share by States (2012-2017)
3.2 United States Irbesartan Revenue and Market Share by States (2012-2017)
3.3 United States Irbesartan Price by States (2012-2017)

4 UNITED STATES IRBESARTAN SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2012-2017)

4.1 United States Irbesartan Sales and Market Share by Type (2012-2017)
4.2 United States Irbesartan Revenue and Market Share by Type (2012-2017)
4.3 United States Irbesartan Price by Type (2012-2017)
4.4 United States Irbesartan Sales Growth Rate by Type (2012-2017)

5 UNITED STATES IRBESARTAN SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Irbesartan Sales and Market Share by Application (2012-2017)
5.2 United States Irbesartan Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES IRBESARTAN MANUFACTURERS PROFILES/ANALYSIS

6.1 Teva(TAPI)?
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Irbesartan Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Teva(TAPI)? Irbesartan Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Taj Pharmaceuticals
  6.2.2 Irbesartan Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Taj Pharmaceuticals Irbesartan Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Zhuhai Rundu Pharmaceutical
  6.3.2 Irbesartan Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Zhuhai Rundu Pharmaceutical Irbesartan Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 HEC Group
  6.4.2 Irbesartan Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 HEC Group Irbesartan Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Zhuhai Rundu Pharmaceutical
  6.5.2 Irbesartan Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Zhuhai Rundu Pharmaceutical Irbesartan Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 ISHITA ACTIVE PHARMA INGREDIENTS (API)
  6.6.2 Irbesartan Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 ISHITA ACTIVE PHARMA INGREDIENTS (API) Irbesartan Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Verdant Life Sciences
  6.7.2 Irbesartan Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Verdant Life Sciences Irbesartan Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview

7 IRBESARTAN MANUFACTURING COST ANALYSIS

7.1 Irbesartan Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Irbesartan

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Irbesartan Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Irbesartan Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES IRBESARTAN MARKET FORECAST (2017-2022)

11.1 United States Irbesartan Sales, Revenue Forecast (2017-2022)
11.2 United States Irbesartan Sales Forecast by Type (2017-2022)
11.3 United States Irbesartan Sales Forecast by Application (2017-2022)
11.4 Irbesartan Price Forecast (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Irbesartan
Table Classification of Irbesartan
Figure United States Sales Market Share of Irbesartan by Type in 2015
Table Application of Irbesartan
Figure United States Sales Market Share of Irbesartan by Application in 2015
Figure United States Irbesartan Sales and Growth Rate (2012-2022)
Figure United States Irbesartan Revenue and Growth Rate (2012-2022)
Table United States Irbesartan Sales of Key Manufacturers (2015 and 2016)
Table United States Irbesartan Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Irbesartan Sales Share by Manufacturers
Figure 2016 Irbesartan Sales Share by Manufacturers
Table United States Irbesartan Revenue by Manufacturers (2015 and 2016)
Table United States Irbesartan Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Irbesartan Revenue Share by Manufacturers
Table 2016 United States Irbesartan Revenue Share by Manufacturers
Table United States Market Irbesartan Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Irbesartan Average Price of Key Manufacturers in 2015
Figure Irbesartan Market Share of Top 3 Manufacturers
Figure Irbesartan Market Share of Top 5 Manufacturers
Table United States Irbesartan Sales by States (2012-2017)
Table United States Irbesartan Sales Share by States (2012-2017)
Figure United States Irbesartan Sales Market Share by States in 2015
Table United States Irbesartan Revenue and Market Share by States (2012-2017)
Table United States Irbesartan Revenue Share by States (2012-2017)
Figure Revenue Market Share of Irbesartan by States (2012-2017)
Table United States Irbesartan Price by States (2012-2017)
Table United States Irbesartan Sales by Type (2012-2017)
Table United States Irbesartan Sales Share by Type (2012-2017)
Figure United States Irbesartan Sales Market Share by Type in 2015
Table United States Irbesartan Revenue and Market Share by Type (2012-2017)
Table United States Irbesartan Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Irbesartan by Type (2012-2017)
Table United States Irbesartan Price by Type (2012-2017)
Figure United States Irbesartan Sales Growth Rate by Type (2012-2017)
Table United States Irbesartan Sales by Application (2012-2017)
Table United States Irbesartan Sales Market Share by Application (2012-2017)
Figure United States Irbesartan Sales Market Share by Application in 2015
Table United States Irbesartan Sales Growth Rate by Application (2012-2017)
Figure United States Irbesartan Sales Growth Rate by Application (2012-2017)
Table Teva(TAPI)? Basic Information List
Table Teva(TAPI)? Irbesartan Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Teva(TAPI)? Irbesartan Sales Market Share (2012-2017)
Table Taj Pharmaceuticals Basic Information List
Table Taj Pharmaceuticals Irbesartan Sales, Revenue, Price and Gross Margin (2012-2017)
Table Taj Pharmaceuticals Irbesartan Sales Market Share (2012-2017)
Table Zhuhai Rundu Pharmaceutical Basic Information List
Table Zhuhai Rundu Pharmaceutical Irbesartan Sales, Revenue, Price and Gross Margin (2012-2017)
Table Zhuhai Rundu Pharmaceutical Irbesartan Sales Market Share (2012-2017)
Table HEC Group Basic Information List
Table HEC Group Irbesartan Sales, Revenue, Price and Gross Margin (2012-2017)
Table HEC Group Irbesartan Sales Market Share (2012-2017)
Table Zhuhai Rundu Pharmaceutical Basic Information List
Table Zhuhai Rundu Pharmaceutical Irbesartan Sales, Revenue, Price and Gross Margin (2012-2017)
Table Zhuhai Rundu Pharmaceutical Irbesartan Sales Market Share (2012-2017)
Table ISHITA ACTIVE PHARMA INGREDIENTS (API) Basic Information List
Table ISHITA ACTIVE PHARMA INGREDIENTS (API) Irbesartan Sales, Revenue, Price and Gross Margin (2012-2017)
Table ISHITA ACTIVE PHARMA INGREDIENTS (API) Irbesartan Sales Market Share (2012-2017)
Table Verdant Life Sciences Basic Information List
Table Verdant Life Sciences Irbesartan Sales, Revenue, Price and Gross Margin (2012-2017)
Table Verdant Life Sciences Irbesartan Sales Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Irbesartan
Figure Manufacturing Process Analysis of Irbesartan
Figure Irbesartan Industrial Chain Analysis
Table Raw Materials Sources of Irbesartan Major Manufacturers in 2015
Table Major Buyers of Irbesartan
Table Distributors/Traders List
Figure United States Irbesartan Production and Growth Rate Forecast (2017-2022)
Figure United States Irbesartan Revenue and Growth Rate Forecast (2017-2022)
Table United States Irbesartan Production Forecast by Type (2017-2022)
Table United States Irbesartan Consumption Forecast by Application (2017-2022)
Table United States Irbesartan Sales Forecast by States (2017-2022)
Table United States Irbesartan Sales Share Forecast by States (2017-2022)